This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sep 2026 quarter revenue Rs 531.98 lakh versus Rs 687.15 lakh a year ago; loss narrowed
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
By the next day the stock moved 2.9 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone quarter ended September 30, 2026: revenue Rs 531.98 lakh versus Rs 687.15 lakh a year ago, down 22.6%. The after-tax loss narrowed to Rs 15.89 lakh from Rs 43.95 lakh; profit before interest, tax, depreciation and amortisation was 8.0% of revenue versus 2.7%. Standalone half-year: revenue Rs 951.67 lakh, after-tax loss Rs 74.26 lakh and operating cash flow negative Rs 95.71 lakh; borrowings Rs 1,791.77 lakh, 2.57 times equity.
For shareholders, revenue fell, but losses narrowed and margins improved. High borrowings and negative cash flow keep financial risk elevated.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹5.32 Cr | ₹6.87 Cr | −22.6% |
| Operating profit | −₹0.23 Cr | −₹0.44 Cr | loss narrowed |
| Profit after tax | −₹0.16 Cr | −₹0.44 Cr | loss narrowed |
| EBITDA margin | 8.0% | 2.7% | +5.3 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.